TLDR Dutasteride may help shrink prostate cancer tumors.
The document discussed the effects of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer. It was a correction to a previous study by G.L. Andriole and colleagues. The study aimed to evaluate the impact of dutasteride on prostate cancer by examining changes in tumor markers. The findings suggested that dutasteride could influence tumor regression, providing insights into its potential therapeutic role in managing prostate cancer. However, specific details on the study's methodology, sample size, and statistical significance were not provided in the summary.
408 citations,
May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
June 2023 in “Clinica Chimica Acta” Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.
1 citations,
June 2021 in “Singapore Medical Journal” Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.
19 citations,
April 2020 in “Dermatologic Therapy” Dutasteride works better than finasteride for hair loss, with both being safe to use.
January 2015 in “프로그램북(구 초록집)” Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
215 citations,
November 2006 in “Journal of The American Academy of Dermatology” Dutasteride more effective for hair growth, but has more side effects than finasteride.
33 citations,
September 2005 in “PubMed” Dutasteride successfully treated a woman's hair loss when other treatments failed.
